ADAMTS13 and acute myeloid leukemia: Our finding was revealed that ADAMTS13 level is relatively reduced during AML due to the increased inflammatory markers and infections associated with the disease course which increase the VWF multimers increasing the ADAMTS13 consumption or catabolism or inactivation by thrombin [12, 25].